Home       Market Dynamics     Sector Analysis     Company Insights     AI Investing     Strategies     Contact Us     Login             

JOHNSON & JOHNSON (JNJ) Stock Price Prediction and News Highlight
Tue. Nov 18, 2025

Johnson & Johnson is strategically shifting its portfolio to focus on high-growth markets and expanding its cancer treatment offerings, reflecting a commitment to innovation. The company's advancements in psoriatic arthritis treatment and a strong emphasis on surgical robotics position it favorably in an evolving landscape. However, challenges persist in clinical trials, as exemplified by the halt of a key drug trial, which could impact future product development. Overall, while promising innovations emerge, the company faces hurdles that could affect growth and investor sentiment.

The price action of JOHNSON & JOHNSON (JNJ) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The market sentiment at 0.3 is modestly bullish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.There is no clear direction for JNJ since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0.5, and the negative at -0.2 on 2025-11-18. The forces of and Valuation Sentiment (-1) will drive down the price. The forces of Stock Price Trend (0), Sector Price Trend (0), Price Level Sentiment (0), Option Sentiment (0), Market Risk Appetite (0), and Sentiment towards Fundamentals (3) will drive up the price.

The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band.

Earning Release: 2026-01-21 06:30, EPS: $10.36, P/E: 19.31

JNJ
DateAttentionPricePrice
Level
ChangeSMA10
Trend
Trend
Sentiment
Hourly
Trend
Hourly
StdDev
Market
Sentiment
ActionPFund.News
Sentiment
2025-11-180%(0%)    0    0%    0.3          3    -1   
2025-11-170%(0%)    0    0%    0.7          2.6    4   
2025-11-160%(0%)    0    0%    0.8          2.6    -1   
2025-11-150%(0%)    0    0%    0.9          2.5    -1   
2025-11-140%(0%)    0    0%    0.9          2.5    -1   
2025-11-130%(0%)    0    0%    0.9          3.1    -1   
2025-11-120%(0%)    0    0%    1          3.4    -1   
2025-11-110%(0%)    0    0%    0.9          2.9    -1   
2025-11-100%(0%)    0    0%    0.3          2.6    -1   
2025-11-090%(0%)    0    0%    -0.1          0.2    -1   
 
Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position.
Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force.

2025-11-18 17:03:06 The growing focus and investment in oncology by major pharmaceutical companies indicate a significant trend towards specialized cancer treatments in the healthcare market.
2025-11-18 17:03:06 The disciplined and science-first approach taken by Vida Ventures in building its portfolio reflects strong leadership and strategic planning in life sciences investments.
2025-11-18 17:03:06 Recent positive movements in stock indices like DJIA and S&P 500 are noted, suggesting a favorable market landscape for investors.
2025-11-18 17:03:06 The focus is on investment strategies related to oncology, as evidenced by J&J's acquisition aimed at enhancing its cancer treatment portfolio.
2025-11-18 17:03:06 The articles highlight significant mergers and acquisitions in the pharmaceutical sector, particularly focusing on Johnson & Johnson's acquisition of Halda Therapeutics for $3.05 billion as part of an increasing trend in the industry.


About   Contact Us  
Copyright ©2025 TheMarketUnfolds. All rights reserved. Denver, Colorado, USA